Webinars

Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Recorded Zoom Webinars

The Role of Next-Gen Noninvasive Tests (NITs)in NAFLD/NASH

March 17th, 2021

  • NITS use and thinking in real life
    • NAFLD/NASH and NITS
    • Identifying Fibrosis
    • Growing Importance of Steatosis
    • NITs: Simultaneous v. Sequential Us
    • Conclusions

Download Slides

Metabolic and Genetic Liver Diseases - A focus on Wilson Disease

March 9th, 2021

  • Autosomal recessive disorder of copper metabolism
  • Excess copper accumulation in hepatocytes and release of excess copper into other tissues, particularly the brain
  • Liver Disease includes
    • autoimmune type hepatitis
    • fulminant hepatic failure
    • chronic liver disease
  • Rare Condition; 1:30,000 and carrier state of 1:90
  • Higher in China (2-3 fold) and Asian Countries than in the West

Open in YouTube Download Slides

Hepatitis B Virus

February 9th, 2021

  • Replication of HBV
  • More information is needed about use of clotting tests in cirrhosis
  • The Incidence and 5-Year Survival of HCC in United States
  • Global Prevalence of Chronic Hepatitis B
  • Screening for HBV infection
  • Hepatitis B vaccine and impacts
  • Natural History of Chronic HBV

Download Slides

NITS and NASH - What We Know in 2021

February 2nd, 2021

  • Accurate noninvasive tests are strongly needed to identify patients with advanced fibrosis.
    • ALT or AST are not sensitive for NAFLD/NASH alone.
    • Alone, AST, FIB-4, NFS, VCTE lack sufficient PPV to predict NASH and fibrosis.
    • Thus, we need to use combination testing:
      • Sequential (best for primary care) or
      • Simultaneous
    • Many noninvasive tests, alone or in combination, being studied for:
      • Diagnosis of NASH patients with NAS ≥ 4 and fibrosis ≥ F2
      • Assessment of therapeutic response(for drug therapy in near future)
      • Assessment of long-term patient outcomes (for drug therapy in near future)

Open in YouTube Download Slides

Liver Disease, Liver Failure, Cirrhosis and Coagulation - A Paradigm of Awareness

January 29th, 2021

  • Coagulation in chronic liver disease is a complex, “balanced” process
  • More information is needed about use of clotting tests in cirrhosis
  • Risk of thrombosis may be present even in setting of apparent mild, moderate or severe coagulopathy
  • Recognize superimposed conditions: sepsis, uremia, hyperfibrinolysis
  • Start the use of TEG at your institution to help decrease factor use
  • Don’t treat the INR: treat the patient

Open in YouTube Download Slides

When to Transfer Liver Patients to the ICU and to a LT Center

December 18th, 2020

Overview of the Care of the LIVER Patient in the Hospital“when to consider a transfer”


Open in YouTube Download Slides

Screening for Liver Disease: The Work-up and Diagnosis of Acute and Chronic Liver Disease

October 14th, 2020


Open in YouTube Download Slides

New and Advanced Treatment Strategies for Hepatitis B

October 14th, 2020

Presented at the 17th Vietnam National Congress of Cardiology


Open in YouTube Download Slides

When to Transfer Liver Patients to the ICU and to a LT Center

September 24th, 2020

Overview of the Care of the LIVER Patient in the Hospital“when to consider a transfer”


Open in YouTube Download Slides

NASH ASH vs. MAFLD

September 23rd, 2020

NASH ASH vs. MAFLD: Diagnostic and Treatment Implications


Open in YouTube Download Slides

Primary Biliary Cholangitis

September 21st, 2020

Diagnosis and Management of PBC Liver Disease and Other Complications


Open in YouTube Download Slides

Contact Dr. Robert Gish